Modulators of CA2+ release-activated CA2+ (CRAC) channels and pharmaceutical uses thereof
Described herein are compounds that modulate the activity of CRAC channels, methods of making such compounds, pharmaceutical compositions, and medicaments containing such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with CRAC channe...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Greenberg, Milton L Muzaffery, Omed S Newman, Andrew C White, Clayton A Ransom, John T |
description | Described herein are compounds that modulate the activity of CRAC channels, methods of making such compounds, pharmaceutical compositions, and medicaments containing such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with CRAC channel activity. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10213412B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10213412B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10213412B23</originalsourceid><addsrcrecordid>eNqNi00KwjAUBrtxIeodnjtFCib1AjUobtz4s3BVHulXWohJyUs8v4IewNXAMDMtHufQZscpRKHQkan1hiIcWFCyTcOLE9qvXplLbdZke_YeToh9S2PP8ckWOQ2WHWWBUOoREbp5MenYCRY_zorl8XAzpxJjaCDj5_JIzf2qtlpVO6X3uvqneQOVHjht</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Modulators of CA2+ release-activated CA2+ (CRAC) channels and pharmaceutical uses thereof</title><source>esp@cenet</source><creator>Greenberg, Milton L ; Muzaffery, Omed S ; Newman, Andrew C ; White, Clayton A ; Ransom, John T</creator><creatorcontrib>Greenberg, Milton L ; Muzaffery, Omed S ; Newman, Andrew C ; White, Clayton A ; Ransom, John T</creatorcontrib><description>Described herein are compounds that modulate the activity of CRAC channels, methods of making such compounds, pharmaceutical compositions, and medicaments containing such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with CRAC channel activity.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190226&DB=EPODOC&CC=US&NR=10213412B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190226&DB=EPODOC&CC=US&NR=10213412B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Greenberg, Milton L</creatorcontrib><creatorcontrib>Muzaffery, Omed S</creatorcontrib><creatorcontrib>Newman, Andrew C</creatorcontrib><creatorcontrib>White, Clayton A</creatorcontrib><creatorcontrib>Ransom, John T</creatorcontrib><title>Modulators of CA2+ release-activated CA2+ (CRAC) channels and pharmaceutical uses thereof</title><description>Described herein are compounds that modulate the activity of CRAC channels, methods of making such compounds, pharmaceutical compositions, and medicaments containing such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with CRAC channel activity.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi00KwjAUBrtxIeodnjtFCib1AjUobtz4s3BVHulXWohJyUs8v4IewNXAMDMtHufQZscpRKHQkan1hiIcWFCyTcOLE9qvXplLbdZke_YeToh9S2PP8ckWOQ2WHWWBUOoREbp5MenYCRY_zorl8XAzpxJjaCDj5_JIzf2qtlpVO6X3uvqneQOVHjht</recordid><startdate>20190226</startdate><enddate>20190226</enddate><creator>Greenberg, Milton L</creator><creator>Muzaffery, Omed S</creator><creator>Newman, Andrew C</creator><creator>White, Clayton A</creator><creator>Ransom, John T</creator><scope>EVB</scope></search><sort><creationdate>20190226</creationdate><title>Modulators of CA2+ release-activated CA2+ (CRAC) channels and pharmaceutical uses thereof</title><author>Greenberg, Milton L ; Muzaffery, Omed S ; Newman, Andrew C ; White, Clayton A ; Ransom, John T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10213412B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Greenberg, Milton L</creatorcontrib><creatorcontrib>Muzaffery, Omed S</creatorcontrib><creatorcontrib>Newman, Andrew C</creatorcontrib><creatorcontrib>White, Clayton A</creatorcontrib><creatorcontrib>Ransom, John T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Greenberg, Milton L</au><au>Muzaffery, Omed S</au><au>Newman, Andrew C</au><au>White, Clayton A</au><au>Ransom, John T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Modulators of CA2+ release-activated CA2+ (CRAC) channels and pharmaceutical uses thereof</title><date>2019-02-26</date><risdate>2019</risdate><abstract>Described herein are compounds that modulate the activity of CRAC channels, methods of making such compounds, pharmaceutical compositions, and medicaments containing such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with CRAC channel activity.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US10213412B2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Modulators of CA2+ release-activated CA2+ (CRAC) channels and pharmaceutical uses thereof |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T08%3A46%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Greenberg,%20Milton%20L&rft.date=2019-02-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10213412B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |